New perspectives of central nervous system injury and neuroprotection
Author(s)
Bibliographic Information
New perspectives of central nervous system injury and neuroprotection
（International review of neurobiology, v. 102）
Academic Press, 2012
Available at / 4 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Contents of Works
- The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival
- Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair
- The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery
- Neurovascular aspects of amyotrophic lateral sclerosis
- Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection
- Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse
- Central nervous tissue damage after hypoxia and reperfusion in conjunction with cardiac arrest and cardiopulmonary resuscitation: mechanisms of action and possibilities for mitigation
- Interactions between opioids and anabolic androgenic steroids: implications for the development of addictive behavior
- Neurotrophic factors and neurodegenerative diseases: a delivery issue
- Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neuortoxicity: modulatory roles of co-morbidity factors and nanoparticle intoxication
- Alzheimer's disease and amyloid: culprit or coincidence?
- Vacular endothelial growth factor and other angioglioneurins: key molecules in brain development and restoration
Description and Table of Contents
Description
Central nervous system (CNS) diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis affect a large number of populations worldwide for which no suitable cure is currently available. In addition, stroke, nanoparticle intoxication, diabetes, hypertension, and psychostimulant abuse either alone or in combination are capable of inducing potential brain damage. Thus, there is an urgent need to expand our knowledge to find suitable therapeutic strategies to enhance neurorepair processes in such diseases.This volume presents neuroprotection and novel therapeutic strategies developed in the last 5 years by 12 world leaders in the field. The term neuroprotection means rescuing neuronal and non-neuronal cells together. The cerebral endothelium that constitutes the anatomical and physiological site of the blood-brain barrier (BBB) is one of the most important non-neural cells in the CNS. Any distortion of the BBB leads to brain diseases and restoration of the barrier results in neuroprotection. Thus, the BBB appears to be the "gateway" for neurological diseases and neurorepair. However, to treat brain tumors or infarcts, new therapeutic strategies are needed to enhance brain drug delivery using nanotechnology. In addition, apart from conventional drugs, restoration of BBB function could also be achieved by means of antibodies directed against specific proteins, neurotransmitters or exogenous supplement of neurotrophic factors. Since co-morbidity factors e.g., hypertension, diabetes, and exposure of nanoparticles could complicate the pathogenesis of neurological disorders either an enhanced dose of the drug or nanodelivery of a combination of several drugs is needed to achieve neuroprotection.This volume of International Review of Neurobiology is the first to discuss novel therapeutic strategies in situations of neurological disorders in combination with different co-morbidity factors.
Table of Contents
1. The Function and Mechanisms of Nurr1 Action in Midbrain Dopaminergic Neurons, From Development and Maintenance to Survival
Yu Luo
2. Monoclonal Antibodies as Novel Neurotherapeutic Agents in CNS Injury and Repair
Aruna Sharma and Hari S Sharma
3. The Blood-Brain Barrier in Alzheimer's Disease. Novel Therapeutic Targets and Nanodrug delivery
Hari S Sharma, Rudy J Castellani, Mark A Smith and Aruna Sharma
4. Neurovascular Aspects of Amyotrophic Lateral Sclerosis
Maria Carolina O. Rodrigues, Diana G. Hernandez-Ontiveros, Michael K. Louis, Alison E. Willing, Cesario V. Borlongan, Paul R. Sanberg, Julio C. Voltarelli and Svitlana Garbuzova-Davis
5. Quercetin in Hypoxia Induced Oxidative Stress: Novel Target for Neuroprotection
Anand Kumar Pandey, Ranjana Patnaik, Dafin F Muresanu, Aruna Sharma and Hari S. Sharma
6. Environmental Conditions Modulate Neurotoxic Effects of Psychomotor Stimulant Drugs of Abuse
Eugene A. Kiyatkin and Hari S. Sharma
7. Central Nervous Tissue Damage after Hypoxia and Reperfusion in Conjunction with Cardiac Arrest and Cardiopulmonary Resuscitation. Mechanisms of Action and Possibilities for Mitigation
Lars Wiklund, Cecile Martijn, Adriana Miclescu, Egidijus Semenas, Sten Rubertsson and Hari S Sharma
8. Interactions Between Opioids and Anabolic Androgenic Steroids: Implications for The Development of Addictive Behavior
Fred Nyberg and Mathias Hallberg
9. Neurotrophic Factors and Neurodegenerative Diseases: A Delivery Issue
B. Ruozi, D. Belletti, L. Bondioli, A. De Vita, F. Forni, M.A. Vandelli and G. Tosi
10. Neuroprotective effects of cerebrolysin, a mixture of various neurotrophic factors and peptide fragments on the whole body hyperthermia-induced neurotoxicity. Modulatory Roles of co-morbidity factors and nanoparticle intoxication
Hari Shanker Sharma, Aruna Sharma, Herbert Moessler and Dafin Fior Muresanu
11. Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Stephen D. Skaper
12. Vascular Endothelial Growth Factor and Other Angioglioneurins: Key Molecules in Brain Development and Restoration
Jose Vicente Lafuente, Naiara Ortuzar, Harkaitz Bengoetxea, Susana Bulnes and Enrike G. Argandona
by "Nielsen BookData"
